Skip to search formSkip to main contentSkip to account menu

testosterone undecanoate

Known as: Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta), Testosterone 17Beta-Undecylate, testosterone undecylate 
The undecanoate ester form of the androgen testosterone, with gonadotropin-secretory inhibiting and hormone replacement activity. As testosterone… 
National Institutes of Health

Related topics

Related topics

25 relations
3 ML testosterone undecanoate 250 MG/ML Injection3 ML testosterone undecanoate 250 MG/ML Injection [Aveed]AndrostanesBreast Neoplasms, Male

Narrower (3)

AndrodermAveedNebido

Broader (2)

AndrogensTestosterone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome
The decline in testosterone levels found in men with testosterone deficiency syndrome (TDS) is associated with a decrease in bone… 
2011
2011
Electrochemical endotoxin sensors based on TLR4/MD-2 complexes immobilized on gold electrodes.
2011
2011
Alternative markers for the long-term detection of oral testosterone misuse
2007
2007
A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate
Introduction. This is a four-year follow-up of 25 men who received parenteral testosterone undecanoate (TU), 1000 mg every 12… 
Review
2006
Review
2006
New approaches for male fertility control: HE6 as an example of a putative target
2003
2003
Pharmacokinetic Study in Women of Three Different Doses of a New Formulation of Oral Testosterone Undecanoate, Andriol Testocaps
Study Objective. To assess the pharmacokinetic parameters of testosterone undecanoate after administration of a new oral… 
Highly Cited
1992
Highly Cited
1992
Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.
Therapeutic induction of puberty using oral testosterone (T) undecanoate (TU) 40 mg daily was performed in 4 pubertal boys aged… 
1981
1981
CLINICAL EFFICACY OF TESTOSTERONE UNDECANOATE IN MALE HYPOGONADISM
Testosterone undecanoate (Restandol, Organon Laboratories Ltd * ) dissolved in oleic acid, was administered orally to seventy‐six… 
Highly Cited
1978
Highly Cited
1978
EFFECTS OF ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MALE PATIENTS *
Effects on plasma T, DHT, A, FSH, LH and PRL concentrations and the pituitary responsiveness to the LHRH/TRH stimulation, as well… 
1975
1975
Testosterone undecanoate: a new orally active androgen.
Oral testosterone undecanoate (TU) in arachis oil has been evaluated with a view to its possible use as a means of androgen… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)